(Q84066775)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553278%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

The use of low-dose etanercept as an alternative therapy for treatment of ankylosing spondylitis: a case series (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553278%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

main subject

ankylosing spondylitis

1 reference

Jamileh Moghimi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553278%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Mehrdad Sheikhvatan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553278%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Vahid Semnani

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553278%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

8 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553278%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553278%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553278%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553278%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

2271-2274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553278%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00296-011-1920-0

31 January 2020

exact match

0 references

cites work

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis

1 reference

12 December 2020

Extended dosing of etanercept 25 mg can be effective in patients with ankylosing spondylitis: a retrospective analysis

1 reference

12 December 2020

Etanercept 25 mg/week is effective enough to maintain remission for ankylosing spondylitis among Korean patients

1 reference

12 December 2020

Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society

1 reference

12 December 2020

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

1 reference

12 December 2020

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

1 reference

12 December 2020

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

12 December 2020

New light on uveitis in ankylosing spondylitis

1 reference

12 December 2020

Etanercept: a review of its use in the management of rheumatoid arthritis

1 reference

12 December 2020

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

12 December 2020

Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis

1 reference

12 December 2020

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

12 December 2020

Problems encountered during anti-tumour necrosis factor therapy

1 reference

12 December 2020

Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again)

1 reference

12 December 2020

The cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in the UK.

1 reference

12 December 2020

Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis

1 reference

12 December 2020

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

1 reference

12 December 2020

Does etanercept induce uveitis?

1 reference

12 December 2020

ASAS/EULAR recommendations for the management of ankylosing spondylitis

1 reference

12 December 2020

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

1 reference

12 December 2020

Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy

1 reference

12 December 2020